Anti-HTLV III ELISA and western blot testing in a blood donor population: implications for donor notificationKLEINMAN, S; ANTON-GUIRGIS, H; DWIGHT CULVER, B et al.Vox sanguinis (Basel. 1956). 1986, Vol 51, Num 2, pp 143-147, issn 0042-9007Article

Decision analysis of the HTLV-III screening test for blood donorsELLWEIN, L. B; PURTILO, D. T; PURTILO, R. B et al.AIDS research. 1986, Vol 2, Num 1, pp 5-17, issn 0737-6006Article

Serial transmission of human T-cell leukemia virus type I by blood transfusion in rabbits and its prevention by use of X-irradiated stored bloodKOTANI, S; YOSHIMOTO, S; YAMATO, K et al.International journal of cancer. 1986, Vol 37, Num 6, pp 843-847, issn 0020-7136Article

Antibodies to LAV in various population groups of the Central African RepublicGEORGES, A; LESBORDES, J. L; MEUNIER, D. M. Y et al.Annales de l'Institut Pasteur. Virologie. 1985, Vol 136, Num 4, pp 323-325, issn 0769-2617Article

Characterization of gp41 As the transmembrane protein coded by the HTLV-III/LAV envelope geneDI MARZO VERONESE, F; DE VICO, A. L; COPELAND, T. D et al.Science (Washington, D.C.). 1985, Vol 229, Num 4720, pp 1402-1405, issn 0036-8075Article

Immunologic dysfunction in infants infected through transfusion with HTLV-IIIWYKOFF, R. F; PEARL, E. R; SAULSBURY, F. T et al.The New England journal of medicine. 1985, Vol 312, Num 5, pp 294-296, issn 0028-4793Article

Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virusMARTIN, L. S; MCDOUGAL, J. S; LOSKOSKI, S. L et al.The Journal of infectious diseases. 1985, Vol 152, Num 2, pp 400-403, issn 0022-1899Article

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west AfricaBARIN, F; DENIS, F; ALLAN, J. S et al.Lancet (British edition). 1985, Num 8469-8470, pp 1387-1389, issn 0140-6736Article

Symposium on HTLV, december 6-7, 1984 Bethesda MDBRODER, S.Cancer research (Baltimore). 1985, Vol 45, Num 9, issn 0008-5472, 191 p.Conference Proceedings

Inhibition of HTLV-III/LAV replication by foscarnetSARIN, P. S; TAGUCHI, Y; SUN, D et al.Biochemical pharmacology. 1985, Vol 34, Num 22, pp 4075-4079, issn 0006-2952Article

Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirusWILLEY, R. L; RUTLEDGE, R. A; DIAS, S et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 14, pp 5038-5042, issn 0027-8424Article

Aspects cliniques de l'infection par le virus LAV/HTLV-III = Clinical aspects of LAV/HTLV-III virus infectionROZENBAUM, W; GHARAKHANIAN, S.Concours médical (Paris). 1986, Vol 108, Num 25, pp 2113-2116, issn 0010-5309Article

HTLV-III serology in hemophilia: relationship with immunologic abnormalitiesGILL, J. C; MENITOVE, J. E; ANDERSON, P. R et al.The Journal of pediatrics. 1986, Vol 108, Num 4, pp 511-516, issn 0022-3476Article

The trans-activator gene of HTLV-III is essential for virus replicationFISHER, A. G; FEINBERG, M. B; WONG-STAAL et al.Nature (London). 1986, Vol 320, Num 6060, pp 367-371, issn 0028-0836Article

Spectrum of human T-cell lymphotropic virus type III infection in children: recognition of symptomatic, asymptomatic, and seronegative patientsSAVITA PAHWA; KAPLAN, M; FIKRIG, S et al.JAMA, the journal of the American Medical Association. 1986, Vol 255, Num 17, pp 2299-2305, issn 0098-7484Article

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroMITSUYA, H; WEINHOLD, K. J; FURMAN, P. A et al.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 20, pp 7096-7100, issn 0027-8424Article

Recombinant human interferon alfa-A supresses HTLV-III replication in vitroHO, D. D; ROTA, T. R; KAPLAN, J. C et al.Lancet (British edition). 1985, Num 8429, pp 602-604, issn 0140-6736Article

Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentivirusesGONDA, M. A; BRAUN, M. J; CLEMENTS, J. E et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 11, pp 4007-4011, issn 0027-8424Article

Prevalence of human T-lymphotropic virus type III antibodies among patients in dialysis programs at a University HospitalMORRISON, A. J. JR; FREER, C. V; LYNN POOLE, C et al.Annals of internal medicine. 1986, Vol 104, Num 6, pp 805-807, issn 0003-4819Article

Defective postbinding lysis underlies the impaired natural killer activityin factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacsKATZMAN, M; LEDERMAN, M. M.The Journal of clinical investigation. 1986, Vol 77, Num 4, pp 1057-1062, issn 0021-9738Article

Natural killer cell activity from hemophiliacs exhibits differential responses to various forms of interferonMATHESON, D. S; GREEN, B. J; MAN-CHIU POON et al.Blood. 1986, Vol 67, Num 1, pp 164-167, issn 0006-4971Article

Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factorMCDOUGAL, J. S; MARTIN, L. S; CORT, S. P et al.The Journal of clinical investigation. 1985, Vol 76, Num 2, pp 875-877, issn 0021-9738Article

Transmission of lymphotropic retroviruses (HTLV-1 and LAV/HTLV-III) by blood transfusion and blood productsMELIEF, C. J. M; GOUDSMIT, J.Vox sanguinis (Basel. 1956). 1986, Vol 50, Num 1, pp 1-11, issn 0042-9007Article

Sida: généralités = AIDS: generalitiesDE MAUBEUGE, J; CLUMECK, N.Les Nouvelles dermatologiques. 1986, Vol 5, pp 162-167, issn 0752-5370, suppl. 2Article

Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applicationsWEISS, S. H; GOEDERT, J. J; SARNGADHARAN, M. G et al.JAMA, the journal of the American Medical Association. 1985, Vol 253, Num 2, pp 221-225, issn 0098-7484Article